6 firms writing Biotech checks in Emeryville, led by Mayfield Fund, Allen & Company, Baruch Future Ventures — ranked by verified deal count.
Biotech in Emeryville accounts for 3 tracked companies with verified cap-table data, 3 of which disclose round sizes totalling $176M. The median disclosed raise is $46M, and the largest is Octant Bio at $115M, ahead of RegCell ($46M) and Andes ($15M).
The names that recur most often on these biotech cap tables are Catalio Capital Management (1 company), Andreessen Horowitz Bio Fund (1 company), Allen & Co. (1 company), 50 Years VC (1 company), Bristol Myers Squibb (1 company), Fast Track Initiative (1 company). By latest disclosed round, the market skews Series B (1), Seed (1), Series A (1).
All research · Investor directory · Company funding database · Fundraising library